| Date & Time | 5 November 2025 at 12.00-13.00 CET |
|---|---|
| Location | Online |
Please save the date for Bridging Nordic ATMP, the new season of ATMP Webinar Series hosted by the Nordic EATRIS Nodes (Sweden, Norway and Finland). This season of the series will take place online 12.00-13.00 CEST, once a month with a lecture by an expert in the Advanced Therapy Medicinal Products (ATMPs) field. The next edition will feature the following speaker:
Özcan Met, PhD, Associate Professor and Head of Cell Therapy Unit, at CCIT-DK and DTU HealthTech will be speaking on Translating Science into Therapies Through ATMP Development at the National Centre for Cancer Immune Therapy
Özcan Met has headed the Cell Therapy Unit at the National Centre for Cancer Immune Therapy in Denmark since 2010, directing all operational activities required for the manufacturing of cellular products intended for use in clinical trials. As Head of Cell Therapy, he has been responsible for the release of over 200 cell therapy products in Phase I, II, and III immunotherapy clinical trials. Özcan has more than 20 years of research experience in tailoring the immune system to combat cancer and leads a team at the cutting edge in the development of novel cell-based technologies for patient treatment.
Register for the webinar here.
Remember to save the dates and look out for updates on each webinar before the start of the event.
The next webinar will take place on:
- 3 December 2025
The previous events took place on:
- 5 February 2025 – Magnus Essand, Professor of Gene Therapy, Uppsala University, Chief Scientific Officer and co-founder, Elicera Therapeutics
- 12 March 2025 – David Morrow, EATRIS Senior Scientific Programme Manager
- 2 April 2025 – Seppo Ylä-Herttuala, Professor at the University of Eastern Finland
- 7 May 2025 – Kamal Mustafa, Professor at the University of Bergen
- 4 June 2025 – Marie Gårdmark, Co-founder of RegSmart Life Science AB and Anna Pasetto, Director of the Centre for Advanced Cell Therapy (ACT) at Oslo University Hospital
- 3 September 2025 – Janet Hoogstraate, Chief Executive Officer at NorthX Biologics
- 1 October 2025 – Joel Clinton Glover, Director of Norwegian Core Facility for Human Pluripotent Stem Cells at the University of Oslo and Oslo University Hospital.
